“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype
P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype
Reviews
There are no reviews yet.
Be the first to review “Article: P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype” Cancel reply
Reviews
There are no reviews yet.